搜尋結果
ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for ...
Bastillepost· 3 日前ImmunityBio, Inc. ( NASDAQ: IBRX ), an immunotherapy company, today announced that the U.S. ...
A Craft Lover’s Guide To Ginza: 8 Traditional Japanese Stores To Visit
Forbes· 3 日前From gleaming luxury flagship stores to award-winning cocktail dens like Bar High Five and ...
Uber, Lyft ask US Supreme Court to block state officials from skirting arbitration mandates
Reuters· 3 日前, opens new tab are asking the justices to bar state officials from using their enforcement ...
Tesla earnings week spotlights price cuts, Elon's 'balls to the wall' autonomy push
TechCrunch· 3 日前As Tesla gears up to report what will likely be unimpressive financial results for the first ...
Vista Outdoor Shares Rise After It Tells MNC Capital to Raise Offer
The Wall Street Journal· 3 日前said Monday it had advised MNC Capital to up its bid to acquire the company as MNC looks to ...
U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents
Reuters· 3 日前The justices turned away Vanda's appeal of a ruling by the patent-focused U.S. Court of ...
US Supreme Court won't hear U.S. Soccer case over hosting foreign matches
Reuters· 3 日前The U.S. Supreme Court on Monday declined to hear an appeal by U.S. Soccer, leaving it to face ...
To get to zero-waste, hundreds of European cities are spurning incineration
Reuters· 3 日前In 2010, local authorities in Milan were preparing the ground for the city’s second big ...
How The Jordan Brand Classic Can Further Elevate The Nike Brand
Forbes· 3 日前A mile from where Michael Jordan was born at Cumberland Hospital in 1963, a Jumpman logo ...
Private firms can play bigger role in quality growth
China Daily· 3 日前The latest data for the Chinese economy presents a complex picture. This makes it essential for private enterprises to climb ...